| Entry |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Glycopyrrolate (USP); Glycopyrronium bromide (JAN/INN); Cuvposa (TN); Robinul (TN); Seebri breezhaler (TN) | ||||||||||
| Product | GLYCOPYRROLATE (Casper Pharma LLC), GLYRX-PF (Exela Pharma Sciences), GLYCOPYRROLATE (Fresenius Kabi USA), CUVPOSA (Merz Pharmaceuticals), LONHALA MAGNAIR (Sunovion Pharmaceuticals), DARTISLA ODT (Edenbridge Pharmaceuticals LLC.), ROBINUL (West-Ward Pharmaceuticals Corp.) | ||||||||||
| Generic | GLYCOPYRROLATE (A-S Medication Solutions), GLYCOPYRROLATE (A-S Medication Solutions), GLYCOPYRROLATE (A-S Medication Solutions), GLYCOPYRROLATE (A-S Medication Solutions), GLYCOPYRROLATE (Accord Healthcare), GLYCOPYRROLATE (Alembic Labs LLC), GLYCOPYRROLATE (American Health Packaging), GLYCOPYRROLATE (American Regent), GLYCOPYRROLATE (Amneal Pharmaceuticals LLC), GLYCOPYRROLATE (Apotex Corp.), GLYCOPYRROLATE (AuroMedics Pharma LLC), GLYCOPYRROLATE (Aurolife Pharma), GLYCOPYRROLATE (AvKARE), GLYCOPYRROLATE (AvPAK), GLYCOPYRROLATE (BE Pharmaceuticals), GLYCOPYRROLATE (BluePoint Laboratories), GLYCOPYRROLATE (Bryant Ranch Prepack), GLYCOPYRROLATE (Bryant Ranch Prepack), GLYCOPYRROLATE (Bryant Ranch Prepack), GLYCOPYRROLATE (Bryant Ranch Prepack), GLYCOPYRROLATE (Bryant Ranch Prepack), GLYCOPYRROLATE (Bryant Ranch Prepack), GLYCOPYRROLATE (Bryant Ranch Prepack), GLYCOPYRROLATE (Bryant Ranch Prepack), GLYCOPYRROLATE (Bryant Ranch Prepack), GLYCOPYRROLATE (Camber Pharmaceuticals), GLYCOPYRROLATE (Caplin Steriles Limited), GLYCOPYRROLATE (Cardinal Health), GLYCOPYRROLATE (Cardinal Health), GLYCOPYRROLATE (Civica), GLYCOPYRROLATE (Civica), GLYCOPYRROLATE (Dr. Reddy's Laboratories Limited), GLYCOPYRROLATE (FH2 Pharma LLC), GLYCOPYRROLATE (Fresenius Kabi USA), GLYCOPYRROLATE (Fresenius Kabi USA), GLYCOPYRROLATE (Fresenius Kabi USA), GLYCOPYRROLATE (General Injectables and Vaccines), GLYCOPYRROLATE (General Injectables and Vaccines), GLYCOPYRROLATE (General Injectables and Vaccines), GLYCOPYRROLATE (General Injectables and Vaccines), GLYCOPYRROLATE (Gland Pharma Limited), GLYCOPYRROLATE (Golden State Medical Supply), GLYCOPYRROLATE (HF Acquisition Co LLC), GLYCOPYRROLATE (HF Acquisition Co LLC), GLYCOPYRROLATE (HF Acquisition Co LLC), GLYCOPYRROLATE (HF Acquisition Co LLC), GLYCOPYRROLATE (HF Acquisition Co LLC), GLYCOPYRROLATE (Henry Schein), GLYCOPYRROLATE (Henry Schein), GLYCOPYRROLATE (Henry Schein), GLYCOPYRROLATE (Henry Schein), GLYCOPYRROLATE (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals), GLYCOPYRROLATE (Hikma Pharmaceuticals USA), GLYCOPYRROLATE (Hikma Pharmaceuticals USA), GLYCATE (Intra-Sana Laboratories), GLYCOPYRROLATE (LGM Pharma Solutions), GLYCOPYRROLATE (Leading Pharma), GLYCOPYRROLATE (Major Pharmaceuticals), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Medical Purchasing Solutions), GLYCOPYRROLATE (Meitheal Pharmaceuticals), GLYCOPYRROLATE (Meitheal Pharmaceuticals), GLYCOPYRROLATE (Merz Pharmaceuticals), GLYCOPYRROLATE (NORTHSTAR RX LLC), GLYCOPYRROLATE (Nivagen Pharmaceuticals), GLYCOPYRROLATE (NorthStar Rx LLC), GLYCOPYRROLATE (Par Pharmaceutical), GLYCOPYRROLATE (Par Pharmaceutical), GLYCOPYRROLATE (Piramal Critical Care), GLYCOPYRROLATE (Quinn Pharmaceuticals), GLYCOPYRROLATE (REMEDYREPACK), GLYCOPYRROLATE (REMEDYREPACK), GLYCOPYRROLATE (Rising Pharma Holdings), GLYCOPYRROLATE (Sandoz), GLYCOPYRROLATE (Solco Healthcare US), GLYCOPYRROLATE (Solco Healthcare US), GLYCOPYRROLATE (Somerset Therapeutics), GLYCOPYRROLATE (Somerset Therapeutics), GLYCOPYRROLATE (Xiromed LLC), GLYCOPYRROLATE (Xiromed), GLYCOPYRROLATE (Zydus Pharmaceuticals (USA)), GLYCOPYRROLATE ORAL SOLUTION (Suven Pharmaceuticals Limited), GLYCOPYRROLATE ORAL SOLUTION (Taro Pharmaceuticals U.S.A.) | ||||||||||
| Formula | C19H28NO3. Br | ||||||||||
| Exact mass | 397.1253 | ||||||||||
| Mol weight | 398.3345 | ||||||||||
| Structure |  | ||||||||||
| Simcomp | |||||||||||
| Class | Neuropsychiatric agent DG01491 Muscarinic cholinergic receptor antagonist | ||||||||||
| Remark |
| ||||||||||
| Efficacy | Anti-ulcerative, Bronchodilator, Muscarinic acetylcholine receptor antagonist | ||||||||||
| Disease | Peptic ulcer [DS:H01634] Chronic obstructive pulmonary disease [DS:H01714] | ||||||||||
| Comment | Quaternary ammonium compound | ||||||||||
| Target | CHRM3 [HSA:1131] [KO:K04131] | ||||||||||
| Pathway |
| ||||||||||
| Interaction | |||||||||||
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] A ALIMENTARY TRACT AND METABOLISM A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS A03AB Synthetic anticholinergics, quaternary ammonium compounds A03AB02 Glycopyrronium D00540 Glycopyrrolate (USP) <JP/US> D DERMATOLOGICALS D11 OTHER DERMATOLOGICAL PREPARATIONS D11A OTHER DERMATOLOGICAL PREPARATIONS D11AA Antihidrotics D11AA01 Glycopyrronium D00540 Glycopyrrolate (USP) <JP/US> R RESPIRATORY SYSTEM R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS R03BB Anticholinergics R03BB06 Glycopyrronium bromide D00540 Glycopyrrolate (USP) <JP/US> USP drug classification [BR:br08302] Gastrointestinal Agents Antispasmodics, Gastrointestinal Glycopyrrolate D00540 Glycopyrrolate (USP) Respiratory Tract/Pulmonary Agents Bronchodilators, Anticholinergic Glycopyrrolate D00540 Glycopyrrolate (USP) Therapeutic category of drugs in Japan [BR:br08301] 2 Agents affecting individual organs 22 Respiratory organ agents 225 Bronchodilators 2259 Others D00540 Glycopyrrolate (USP); Glycopyrronium bromide (JAN/INN) Drug groups [BR:br08330] Neuropsychiatric agent DG01491 Muscarinic cholinergic receptor antagonist DG02467 Glycopyrronium D00540 Glycopyrrolate Target-based classification of drugs [BR:br08310] G Protein-coupled receptors Rhodopsin family Acetylcholine (muscarinic) CHRM3 D00540 Glycopyrrolate (USP) <JP/US> New drug approvals in Europe [br08329.html] European public assessment reports (EPAR) authorised medicine D00540 New drug approvals in Japan [br08318.html] Drugs with new active ingredients D00540 Drug groups [BR:br08330] Neuropsychiatric agent DG01491 Muscarinic cholinergic receptor antagonist DG02467 Glycopyrronium | ||||||||||
| Other DBs |
| ||||||||||
| KCF data | ATOM 24 1 C1d C 24.1031 -22.1674 2 C7a C 22.9701 -22.8047 3 O7a O 21.7662 -22.1674 4 O6a O 22.9701 -24.2210 5 C1y C 20.4915 -22.8756 6 C1x C 19.4128 -22.0966 7 C1x C 20.0908 -24.2414 8 N2y N 18.2555 -22.8879 #+ 9 C1x C 18.7293 -24.2018 10 C1y C 25.3216 -22.8892 11 C1x C 25.7607 -24.2172 12 C1x C 27.1619 -24.2138 13 C1x C 27.5915 -22.8800 14 C1x C 26.4559 -22.0593 15 C8y C 24.1031 -20.7511 16 C8x C 25.3296 -20.0429 17 C8x C 25.3296 -18.6266 18 C8x C 24.1031 -17.9184 19 C8x C 22.8766 -18.6266 20 C8x C 22.8766 -20.0429 21 O1a O 25.1880 -21.3176 22 C1a C 17.0289 -22.1798 23 C1a C 17.0289 -23.5960 24 X Br 17.5880 -25.3541 #- BOND 25 1 1 2 1 2 2 3 1 3 2 4 2 4 3 5 1 5 5 6 1 6 5 7 1 7 6 8 1 8 7 9 1 9 8 9 1 10 1 10 1 11 10 11 1 12 11 12 1 13 12 13 1 14 13 14 1 15 10 14 1 16 1 15 1 17 15 16 1 18 16 17 2 19 17 18 1 20 18 19 2 21 19 20 1 22 15 20 2 23 1 21 1 24 8 22 1 25 8 23 1 |